Compensation award — excluded from discretionary-purchase analysis.
Traded Apr 27, 2026 · Filed Apr 29, 2026
Thermo Fisher Scientific's President & COO sold $185K of Thermo Fisher Scientific shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$185,064
Shares × reported transaction price
4 days after results of Apr 23, 2026, 87 days before results of Jul 23, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $468.04 on Apr 27, 2026, 20% above its 52-week low and 27% below its high, little changed over the previous 30 trading days
52-week range $390.26 (Jun 17, 2025) to $639.45 (Jan 22, 2026), 31% of the way up, from 251 adjusted closes. 30 trading days earlier: $464.37 on Mar 13, 2026. Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -0.9% | +1.8% | -2.7% |
| 30 days | +3.1% | +5.5% | -2.4% |
| 90 days | +20.4% | +1.5% | +18.9% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.